2014
DOI: 10.1093/cid/ciu304
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections

Abstract: Our data suggest that clindamycin treatment of patients with severe iGAS infections substantially reduces mortality and that this effect may be enhanced by concurrent treatment with IVIG. The dramatically increased risk of iGAS disease among household contacts within 1 month of the index case highlights a potential role for antibiotic prophylaxis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
125
0
8

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 202 publications
(141 citation statements)
references
References 27 publications
3
125
0
8
Order By: Relevance
“…As demonstrated for pharyngitis, their use may limit antibiotic overprescription and focus the treatment, limiting the side effects and the emergence of antimicrobial resistance (5,23). It may also be helpful for optimizing therapy by adding antitoxin antibiotics, such as clindamycin, and intravenous immunoglobulin, which reduce the risk of fatal outcome (24,25).…”
Section: Discussionmentioning
confidence: 99%
“…As demonstrated for pharyngitis, their use may limit antibiotic overprescription and focus the treatment, limiting the side effects and the emergence of antimicrobial resistance (5,23). It may also be helpful for optimizing therapy by adding antitoxin antibiotics, such as clindamycin, and intravenous immunoglobulin, which reduce the risk of fatal outcome (24,25).…”
Section: Discussionmentioning
confidence: 99%
“…Clindamycin is recommended for necrotizing fasciitis caused by S. pyogenes, based on its suppression of streptococcal toxins and two observational studies showing greater efficacy than with ␤-lactams (377,378). In an additional observational cohort, the addition of clindamycin was associated with reduced mortality due to invasive S. pyogenes infections (379). There are no such data available for S. aureus necrotizing fasciitis, and IDSA guidelines do not specifically recommend the addition of clindamycin in this setting (370).…”
Section: Treatmentmentioning
confidence: 99%
“…Consequently, regarding the research agenda on NSTIs, the IDSA guidelines strongly advocate the development of clinical trials, particularly aimed at assessing treatments targeting staphylococcal and streptococcal NSTIs. These subtypes of NSTIs may indeed present with the classical toxic shock syndrome, for which clindamycin should be combined with penicillin in order to suppress streptococcal/staphylococcal toxins as well as cytokine production [9]. In this setting, the efficacy of intravenous immunoglobulins (IVIG) remains debated [10].…”
mentioning
confidence: 99%